AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-108402340/trends-amp-innovations-point.html" title="Facts and information about TRENDS & INNOVATIONS.(TO THE POINT)">TRENDS & INNOVATIONS.(TO THE POINT)</a>
Close
Set up an RSS feed that alerts you when new articles from Investor's Business Daily are available.
Frequently asked questions about RSS feeds
TRENDS & INNOVATIONS.(TO THE POINT)
** DeCODE genetics, an Icelandic biotech, has isolated a gene that helps decide if people are predisposed to being overweight or underweight, Icelandic researchers said.
** Scientists have launched a global trial to find out if AstraZeneca's Anastrozole breast cancer drug can prevent the disease in high-risk women. Anastrozole has less side effects than tamoxifen, they said.
** Severely obese people who are depressed often report an easing of their depression after undergoing surgery to get rid of excess pounds, Australian researchers said in Archives ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- FDA ok.(Friday, March 2)(Food and Drug Administration)(Procleix Tigris...
- Magazine article from: San Diego Business Journal Weeks, Katie March 12, 2007 700+ words
FDA OK: Gen-Probe Inc. announced the Food and Drug Administration has approved the San Diego-based company's device to test donated...
- Pfizers FDA OK To Begin Glaucoma Drug Candidate Study, Triggers Payment To...
- News wire article from: The America's Intelligence Wire March 29, 2007 700+ words
(From FinancialWire) Byline: DAVID WEBER FinancialWire-29 March 2007-Pfizers FDA OK To Begin Glaucoma Drug Candidate Study, Triggers Payment To NicOx (C)2007 Investrend Communications, Inc. March 29, 2007...
- FDA OK.(United States. Food and Drug Administration)(Brief article)
- Magazine article from: San Diego Business Journal Weeks, Katie September 4, 2006 700+ words
FDA OK: San Diego's DexCom Inc. received approval from the Food and Drug Administration for a software program used to help diabetes patients manage glucose levels.
- Dr. Reddys Gets FDA OK For Generic Famotidine 20 MG.
- News wire article from: The America's Intelligence Wire September 28, 2006 700+ words
(From FinancialWire) FinancialWire-28 September 2006-Dr. Reddys Gets FDA OK For Generic Famotidine 20 MG (C)2006 Investrend Communications, Inc. September 28, 2006 (FinancialWire) Leiner Health Products...
- Bio-Data gets FDA ok to market product. (Bio-Data Corp.) (product announcement)
- Magazine article from: Philadelphia Business Journal Reichert, Kent December 14, 1987 700+ words
Bio/Data gets FDA OK to market product Hatboro-based Bio/Data Corp. has received clearance from the Food and Drug Administration (FDA) to market...
- GW Medical, assuming FDA OK, set to market 1st AD blood test.
- Magazine article from: Medical Device Week April 8, 2005 700+ words
GW Medical, assuming FDA OK, set to market 1st AD blood test By KAREN YOUNG Medical Device Daily Staff Writer If all goes as planned, GW Medical Technologies...
- Amplatzer device gets FDA OK to close VSD holes in the heart.
- Magazine article from: Medical Device Week September 12, 2007 700+ words
Amplatzer device gets FDA OK to close VSD holes in the heart By OMAR FORD Medical Device Daily Staff Writer Look at the facts. Any physician will quickly point...
- Merck Has Hopes for Arcoxia, But FDA OK May Not Be Among Them.
- News wire article from: The America's Intelligence Wire October 20, 2004 700+ words
(From FinancialWire) FinancialWire-20 October 2004-Merck Has Hopes for Arcoxia, But FDA OK May Not Be Among Them (C)2004 Investrend Communications, Inc. October 20, 2004. (FinancialWire) Mercks (NYSE: MRK...
- Genzyme Releases Promising Results for Kidney Drug and Gilead's Letairis...
- Press release article from: M2 Presswire June 19, 2007 700+ words
...19 June 2007-U.S. Equity News: Genzyme Releases Promising Results for Kidney Drug and Gilead's Letairis Tablets Get FDA OK(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:19062007 City of Industry, CA - Biotechnology industry alert provided by U...
- FDA OK 300mg loading dose of Sanofi's Plavix.
- Newspaper article from: Pharma Marketletter September 27, 2007 700+ words
Sanofi-Aventis and Bristol-Myers Squibb say that the US Food and Drug Administration has approved a supplemental New Drug Application for a 300mg tablet of their antiplatelet agent Plavix (clopidogrel The 300mg tablet will facilitate the use of the FDA-approved loading dose for appropriate acute
